Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Publication year range
1.
BMC Infect Dis ; 11: 306, 2011 Nov 02.
Article in English | MEDLINE | ID: mdl-22047047

ABSTRACT

BACKGROUND: A paradoxical immunologic response (PIR) to Highly Active Antiretroviral Therapy (HAART), defined as viral suppression without CD4 cell-count improvement, has been reported in the literature as 8 to 42%, around 15% in most instances. The present study aims to determine, in a cohort of HIV infected patients in Brazil, what factors were independently associated with such a discordant response to HAART. METHODS: A case-control study (1:4) matched by gender was conducted among 934 HIV infected patients on HAART in Brazil. CASES: patients with PIR, defined as CD4 < 350 cells/mm(3) (hazard ratio for AIDS or death of at least 8.5) and undetectable HIV viral load on HAART for at least one year. CONTROLS: similar to cases, but with CD4 counts ≥ 350 cells/mm(3). Eligibility criteria were applied. Data were collected from medical records using a standardized form. Variables were introduced in a hierarchical logistic regression model if a p-value < 0.1 was determined in a bivariate analysis. RESULTS: Among 934 patients, 39 cases and 160 controls were consecutively selected. Factors associated with PIR in the logistic regression model were: total time in use of HAART (OR 0.981; CI 95%: 0.96-0.99), nadir CD4-count (OR 0.985; CI 95%: 0.97-0.99), and time of undetectable HIV viral load (OR 0.969; CI 95%: 0.94-0.99). CONCLUSIONS: PIR seems to be related to a delay in the management of immunodeficient patients, as shown by its negative association with nadir CD4-count. Strategies should be implemented to avoid such a delay and improve the adherence to HAART as a way to implement concordant responses.


Subject(s)
Anti-HIV Agents/administration & dosage , Antiretroviral Therapy, Highly Active/methods , HIV Infections/drug therapy , HIV Infections/immunology , Viral Load , Adult , Brazil , CD4 Lymphocyte Count , Case-Control Studies , Cohort Studies , Female , HIV Infections/virology , Humans , Male , Middle Aged , Risk Factors , Treatment Outcome
SELECTION OF CITATIONS
SEARCH DETAIL
...